Trading Platform Evolve Markets  Forex, commodities, indices and cryptocurrency trading platform Evolve Markets have announced

Bitcoin-denominated Trading Platform Evolve Markets Proudly Announces Increased Bitcoin Leverage at 25X

 

Online trading platform Evolve Markets has announced it will be increasing the amount of leverage it offers.

 Trading Platform Evolve Markets  Forex, commodities, indices and cryptocurrency trading platform Evolve Markets have announced

BUZ INVESTORS PRESS RELEASE  Trading Platform Evolve Markets  Forex, commodities, indices and cryptocurrency trading platform Evolve Markets have announced that they will be increasing their Bitcoin leverage to 25X, along with some additional changes to their service.

The new increased 25X leverage has been implemented to help users of the platform to trade with less on deposit and is a result of improvements to the platform’s matching engine and growing user base. The increased leverage will apply to the pairs BTC/USD, BTC/CNH, BTC/EUR, BTC/USD-micro, and BTC/JPY. The platform has recently enhanced the cryptocurrency spreads on all of their Pro-Accounts.




Trading Platform Evolve Markets

 

Evolve Markets is renowned as a unique trading platform which allows its users to trade Bitcoin against a large number of global macro instruments such as FOREX, commodities, and indices.

Evolve Markets platform boasts of numerous powerful financial tools, institutional liquidity, and high-end Tier 4 institutional infrastructure. Its service offers numerous features such as instant account approval, fast deposits, Bitcoin BIT base currency accounts, up to 1:500 leverage, MetaTrader WebTrader, and negative balance protection.

About Evolve Markets

Evolve Markets is a privately-owned IBC in Saint Vincent and the Grenadines. The trading platform specializes in Bitcoin-denominated accounts and adopts a Straight Through Processing (STP) and Matching execution model. The tradable financial assets supported on the platform include forex, commodities, indices, and cryptocurrencies.

Learn more about Evolve Markets at – https://evolve.markets

|Chart | Calendar   | TRADE NOW | FORCAST | cryptocurrency 

Market Quotes by TradingView

Like up on FACEBOOK


logo




Canopy Growth Corp. (TSX:WEED)(OTC:TWMJF) finished this week’s trading up more than 7%.

Canopy Growth Corp. (TSX:WEED)(OTC:TWMJF) finished this week’s trading up more than 7%.

BUZ INVESTORS Canopy Growth Corp   Canadian licensed producer, Canopy Growth Corp. finished this week’s trading up more than 7%. Last Friday, the company’s subsidiary, rTrees Producers Ltd. received their license to cultivate medical marijuana. Earlier in the week, Canopy Growth released a shareholders’ update, highlighting recent developments at the company.




Canopy Growth Corp

Canada Approves Two More Licensed Producers

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2.0">Earlier today, Health Canada announced that two more medical marijuana producers have obtained their license to cultivate under the Access to Cannabis for Medical Purposes Regulations, or ‘ACMPR’. These two new additions come just after Health Canada granted three new licenses on Monday.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4.0">It is becoming clear that the recent licensing changes at Health Canada have led to a drastic change for the better in regard to the efficiency of the application process. 

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.g.0.0">, Canopy Growth Corp. (TSX:WEED)(OTC:TWMJF) acquired rTrees Producers. Under the Canopy umbrella, rTrees is operating as Tweed Grasslands and will be producing product to be$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.g.0.1"> sold through the Tweed Main Street online store, $SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.g.0.2">among another venues. rTrees Producers has a 90,000 square foot indoor facility that has access to low cost water and power. The facility is currently $SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.g.0.3">20% built out. 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




CannaRoyalty Corp  Shares of the diversified cannabis investor and operator, CannaRoyalty Corp. gained more than 11% in this week’s trading. On Monday,

CannaRoyalty Corp. (CSE:CRZ)(OTC:CNNRF) gained more than 11% in this week’s trading

CannaRoyalty Corp. (CSE:CRZ)(OTC:CNNRF) gained more than 11% in this week’s trading

 CannaRoyalty Corp  Shares of the diversified cannabis investor and operator, CannaRoyalty Corp. gained more than 11% in this week’s trading. On Monday,

BUZ INVESTORS   CannaRoyalty Corp  Shares of the diversified cannabis investor and operator, CannaRoyalty Corp. gained more than 11% in this week’s trading. On Monday, CannaRoyalty announced that the company has raised $12 million CAD (~$9.05 million USD) to form a joint venture to invest in Canadian cannabis companies.




CannaRoyalty Corp

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2.0"> CannaRoyalty Corp. (CSE:CRZ)(CSE:CRZ.CN)(CNSX:CRZ)(OTCQX:CNNRF) (“CannaRoyalty”) is pleased to announce that it has executed a binding term sheet with a Canadian institutional investor (the “Investor”) to complete a $12 million financing and form a joint venture (“JV”) to finance opportunities in the Canadian cannabis market.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4.0">The financing is expected to be comprised of a revolving $12 million secured credit facility with a three year term, of which $6 million will be advanced on closing. The proceeds are expected to be used for specific opportunities that CannaRoyalty is pursuing for production and/or processing assets, as well as general corporate purposes.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.6">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.6.0">The facility will bear interest at an annual rate of 10%, payable quarterly in cash or CannaRoyalty shares. In addition, CannaRoyalty warrants have been issued to the Investor today, which will entitle the Investor to purchase 1.8 million CannaRoyalty shares at an exercise price of $2.05 per share for a period of three years after closing.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.8">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.8.0">The JV is expected to be launched following the closing of the financing and will focus on investment opportunities in the rapidly growing Canadian cannabis market. The Investor is a Canadian institutional investor who will fund and manage the JV. CannaRoyalty will leverage its relationships and investment pipeline to identify and refer attractive Canadian opportunities such as production assets, property and equipment to the JV and also assist the Investor in completing due diligence and providing strategic support to JV investments.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.a">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.a.0">“Our focus on value-add assets in the cannabis sector has given us access to a broad pipeline of unique investment opportunities in Canada. This joint venture gives us a vehicle to participate in these opportunities while leveraging our joint venture partner’s expertise in hard asset lending. This JV will be the first in the cannabis sector and has the potential to provide a true “win-win-win” for target assets, the Investor and CannaRoyalty’s shareholders. Target Canadian assets get access to strategic capital; the Investor gets exposure to returns from highly productive assets in the cannabis sector; and CannaRoyalty attains exposure to accretive investment opportunities,” said Marc Lustig, CEO of CannaRoyalty.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.c">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.c.0">In connection with the foregoing, the Investor has been granted the right to nominate a director for CannaRoyalty’s Board. Closing is expected to occur by July 31, 2017 and is subject to stock exchange approval, execution of definitive documents, completion of satisfactory due diligence, and other conditions.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.e">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.e.0">About CannaRoyalty

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.g">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.g.0">CannaRoyalty is a fully integrated, active investor and operator in the legal cannabis sector. Our focus is building and supporting a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including research, consumer brands, devices and intellectual property. Our management team combines a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a platform of holdings via royalty agreements, equity interests, secured convertible debt, licensing agreements and its own branded portfolio.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




AXIM Biotechnologies gained more than 12% in trading this week. On Monday, the company announced that they have secured $4 million in financing to fund clinical trials

AXIM Biotechnologies Inc. (OTC:AXIM) gained more than 12% in trading this week

AXIM Biotechnologies Inc. (OTC:AXIM) gained more than 12% in trading this week

AXIM Biotechnologies gained more than 12% in trading this week. On Monday, the company announced that they have secured $4 million in financing to fund clinical trials

BUZ INVESTORS  AXIM Biotechnologies gained more than 12% in trading this week. On Monday, the company announced that they have secured $4 million in financing to fund clinical trials of their cannabinoid-infused chewing gum in the treatment of irritable bowel syndrome as well as pain and spasticity associated with multiple sclerosis. This Friday, AXIM announced that they have filed a patent on cannabinoid and opioid infused chewing gum for the treatment of opioid dependency.




AXIM Biotechnologies

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2.0">AXIM Biotechnologies, Inc. (OTC:AXIM) announced today that the company has secured $4 million in institutional financing to further advance its clinical trials for the treatment of irritable bowel syndrome (“IBS”), pain and spasticity in multiple sclerosis (“MS”).

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4.0">In addition to the advancement of AXIM’s clinical trials, the funding will also allow the company to continue a bio-equivalency study on creating an alternative to AbbVie’s (NYSE:ABBV) FDA-approved Marinol drug using the company’s patented chewing-gum delivery system.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.6">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.6.0">Robust Development Pipeline

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.8">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.8.0">“This financing enables us to continue to build on the progress we have made with our cannabinoid clinical development program for indications where there are currently no effective treatments,” said George Anastassov, MD, the CEO of AXIM.

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.a">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.a.0">Anastassov continued, “it is encouraging to see that investors recognize the potential of our robust clinical development pipeline. We are now better positioned to execute on cannabinoid research and commercialization.”

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.a">AXIM’s Chewing Gum Technologies

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.2.0">This morning, AXIM Biotechnologies, Inc. (OTC:AXIM) announced that the company has filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment. The gum may also be used to replace other opioids for the treatment of chronic pain. 

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.4.0">Opioid Addiction…the Problem and a Solution

$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.6">$SITE_ROOT.$desktop_siteRoot.$PAGES_CONTAINER.1.1.$SITE_PAGES.$c1kod_DESKTOP.1.$ppPrt7-lx4.0.0.$child.$0.1.$1.$4.$0.0.6.0">“Opioid addiction is a serious global problem that affects the health, social, and economic welfare of all societies. Opioid addiction therapy depends on a variety of techniques. One of them is the replacement therapy, where an opioid is replaced with another less potent and less addictive opioid that curbs the craving and reduces withdrawal symptoms, while maintaining the person’s mental state such that the person is still able to function normally,” said George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM Biotech

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Ambisafe Announces Orderbook – an Innovative Trading Platform for Ethereum-based ICO Tokens

Ambisafe Announces Orderbook – an Innovative Trading Platform for Ethereum-based ICO Tokens

<script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script> <!-- new 3 --> <ins class="adsbygoogle"      style="display:block"      data-ad-client="ca-pub-7413311789701688"      data-ad-slot="5611514729"      data-ad-format="auto"></ins> <script> (adsbygoogle = window.adsbygoogle || []).push({}); </script>

BUZ INVESTORS  PRESS RELEASE Ambisafe Announces Orderbook  Ambisafe, an Ethereum asset management platform has just announced its newest development – Orderbook, a trading platform for Ethereum-based ICO tokens.

Ambisafe has helped to launch successful ICOs for several blockchain companies, particularly Polybius, TaaS, and Chronobank. The Polybius ICO has so far raised over $21.2 million dollars, whilst the TaaS ICO has raised over $7.5 million dollars with over 3,900 investors.

Orderbook, a new venture organized by the team behind Ambisafe, is a trading platform for Ethereum-based ICO tokens. Through this trading platform, ICO participants can take advantage of cutting edge security, in which all critical operations are executed via Ethereum smart contracts, and all assets will be held “on-chain”.

All asset information will be available on the platform including dividend history, trading protocols, transaction volumes and analytics from trusted cryptocurrency sources.




Ambisafe Announces Orderbook  

Furthermore, The Orderbook exchange platform will streamline operations and ensure transparency for both ICO founders and traders. Since the platform is implemented as a set of smart contracts, all trade history will be available for audit to ensure that there are no fraudulent manipulations. The unique trading interface will contain additional information about companies and provide the ability to receive dividends directly for traders, thus creating an efficient, transparent and versatile environment for the cryptocurrency industry.

To learn more about Orderbook:
● Website: https://orderbook.io/
● Facebook: https://www.facebook.com/orderbookio
● Twitter: https://twitter.com/orderbook_io
● Telegram: https://t.me/joinchat/AAAAAA2i5AUMn3RpatYG5Q

|Chart | Calendar   | TRADE NOW | FORCAST | cryptocurrency 

Market Quotes by TradingView

Like up on FACEBOOK


logo




Compcoin Announces   Compcoin, the digital coin catering to investors and forex traders, today announced terms for its upcoming Initial Coin Offering (ICO), which is scheduled for June 14, 2017. The company hopes to raise up to $45

Compcoin Announces $45M Initial Coin Offering For Its A.I. Trading Platform

Compcoin Announces $45M Initial Coin Offering For Its A.I. Trading Platform

 Compcoin Announces   Compcoin, the digital coin catering to investors and forex traders, today announced terms for its upcoming Initial Coin Offering <span data-recalc-dims=(ICO), which is scheduled for June 14, 2017. The company hopes to raise up to $45 " width="300" height="180" srcset="https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/06/Bitcoin-PR-Buzz-Compcoin-Trading-ICO.png?resize=300%2C180 300w, https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/06/Bitcoin-PR-Buzz-Compcoin-Trading-ICO.png?resize=768%2C461 768w, https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/06/Bitcoin-PR-Buzz-Compcoin-Trading-ICO.png?w=1000 1000w" sizes="(max-width: 300px) 100vw, 300px" />

BUZ INVESTORS  PRESS RELEASE   Compcoin Announces   Compcoin, the digital coin catering to investors and forex traders, today announced terms for its upcoming Initial Coin Offering (ICO), which is scheduled for June 14, 2017. The company hopes to raise up to $45 million, which will go toward the development of new investor technologies, customer acquisition and company growth.

Compcoin is a new digital token focused on investing and growing capital. Investors may buy and hold Compcoin to leverage it as an alternative investment vehicle. However, the primary function of Compcoin is to grant investors access to ART – a proprietary, automated, algorithmic trading platform developed by its parent company, the Fintech Investment Group.

“Compcoin is the first digital coin that grants investors access the world of algorithmic trading in the $5 trillion per day foreign currency market. Previously, such technology had only been available to elite investors, hedge fund managers, large insurers, pension funds and global banks,”

Said Alan Friedland, founder of Fintech Investment Group and Compcoin.

“After eight years of testing, which resulted in highly successful predictions and high returns, we believe Compcoin is ready to generate profits for forex traders on the open market. By making our proprietary trading technology available to everyday investors, Compcoin is leveling the investor playing field and giving owners a real opportunity to experience success in this highly desirable asset class.”




Compcoin Announces

As part of its ICO, Compcoin will be offering 3 million coins at a price of $15 USD each. The first 700,000 coins will receive a 20% bonus. Further details on the bonus program can be found in the offer memorandum released today at www.compcoin.com. Investors can reserve their coins to the ICO by contacting Compcoin at 888-377-COIN (2646). If all 3 million coins are reserved prior to the ICO date, the coins will be issued on an exchange or exchanges within two to three business days after the ICO.

As of today, more than 4.6 million Compcoins have been minted since its introduction in 2014 – an average of 35 new coins every 10 minutes. The maximum number of Compcoin that will be minted is 10 million, or however many coins have been mined by the end of January 2020 — whichever milestone is reached sooner. A percentage of coins will be available for miners.

The more Compcoin an investor owns, the more money the investor can leverage for forex trades with ART. Since the supply of Compcoin will be limited, this demand will increase the value of Compcoin for long-term investors, forex traders and speculators on the open market.

Investors who are interested in learning more about Compcoin are invited to review the company’s offer memorandum. Highlights from the offer memorandum include:

  • Purchasing Compcoin only provides access to ART. Compcoin owners looking to execute forex trades via ART must set up and fund an account with the brokerage of their choice, and then link it to ART. At this time, Compcoin may not be used to fund forex trades.
  • The ability for Compcoin to store value, and potentially increase in value, off-sets any traditional account management fees that retail forex traders would have normally paid to execute trades. Instead of paying fees to a third party, Compcoin investors can use those dollars to purchase a digital asset that can be traded or sold for a potential profit at a later date.
  • Compcoin are transferable and divisible, and exhaust when used to activate the ART trading technology at a rate of 0.5% each quarter. Once a coin is exhausted, it may no longer be used or traded and new Compcoin must be acquired.

 

 

 

About Compcoin

Compcoin is a unique, innovative, US-based digital asset that focuses on investing and increasing earnings growth, instead of spending or other transactional purposes. Compcoin is designed to be a financial asset superior in its ability to store long-term value. Investors may buy Compcoin to leverage it as an alternative investment vehicle – similar to the way investors buy, hold and sell other asset classes (e.g., equities, bonds, commodities, precious metals, etc.). The primary function of Compcoin is to grant investors access to ART – a proprietary and automated artificial intelligence trading platform. Compcoin seeks to be a trusted alternative investment vehicle for serious individual investors and a platform for financial growth. In order to do this, Compcoin focuses on technology, transparency, security, compliance, and financial control. For more info visit www.compcoin.com or call 888-377-COIN.

 

|Chart | Calendar   | TRADE NOW | FORCAST | cryptocurrency 

Market Quotes by TradingView

Like up on FACEBOOK


logo




BUZ INVESTORS HourpayLtd Nowadays the use of cryptocurrencies is gaining widespread popularity across the globe.

Hourpayltd Announces Its Intuitive Platform For Trading In Cryptocurrencies

|Chart | Calendar   | TRADE NOW | FORCAST | cryptocurrency 

BUZ INVESTORS Hourpayltd Trading in currency and foreign exchange is common around the world. It requires experience and proper

BUZ INVESTORS PRESS RELEASE  Hourpayltd  Trading in currency and foreign exchange is common around the world. It requires experience and proper guidance in order to get proper returns. There are various firms around the world that provide trading opportunities to different investors. Today cryptocurencies have come up as an alternative to real money and they are being accepted in many countries. One of the firms that have experience in providing traders an opportunity to trade in cryptocurrency involves HourPayLtd.

After making a proper research in this field traders can easily trust HourPayLtd. Before making any investment it is always important to make proper research in that field. Traders can have a look at the testimonials provided by previous clients and they can also read the details provided on the website. A detailed research will always help in making a smart decision. The company also provides a live chat facility on its website in order to help the clients to stay in touch with their experienced professionals.



Hourpayltd


In trading and forex markets it is always important to get guidance from experienced people. If one does not get proper guidance then it can be disastrous for him or her. HourPayLtd provides instant per hour payment feature that can be helpful for short term traders. There are different plans and the investors can suit the one that meets their needs. Minimum deposit starts from $20 and it goes on to $5000. One can start with small investment and start by learning the tricks of the trade. Once they start getting expected returns then they can start putting in more money. There are three main plans mentioned on the company website that includes returns of 1.1 to 1.5%, 2.2 to 2.5% and 6 to 10%.

The hour fast pay feature is an added advantage that helps the traders in depositing and withdrawing at a faster rate. The updates are provided in the platform and it is important for the traders to keep a track of the statistics. The market conditions keep fluctuating at a fast rate and one should study all the aspects of the market. The investors should make it a point to go through the FAQ and the terms of use in order to get rid of any kind of problems. Opening an account is really easy and one can expect to start the trading within minutes after opening the account. They can login to their backend and keep a check of their trades whenever they want.

About HourPayLtd:

HourPayLtd is a company based in United Kingdom and it has been involved in trading cryptocurrencies. People from different parts of the world can use their platform and start trading through their website. They keep updating their clients about the hourly trades and guide them throughout the trading process. To know more about the company one can visit the above mentioned website.

 

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




BUZ INVESTORS PRESS RELEASE Maricann Group Inc. (CSE: MARI) ("Maricann" or the "Company"), a low cost, greenhouse producer of medical cannabis with market leading technological differentiation

Maricann Group Celebrates Completion of RTO and First Day of Trading

Maricann Group Celebrates Completion of RTO and First Day of Trading

 

 BUZ INVESTORS PRESS RELEASE   Maricann Group Inc. (CSE: MARI) ("Maricann" or the "Company"), a low cost, greenhouse producer of medical cannabis with market leading technological differentiation

BUZ INVESTORS PRESS RELEASE   Maricann Group Inc. (CSE: MARI) (“Maricann” or the “Company”), a low cost, greenhouse producer of medical cannabis with market leading technological differentiation, will begin trading today on the Canadian Securities Exchange (“CSE”) under the stock symbol “MARI”.

“We have been building a very strong foundation to all aspects of our business over the last four years,” said Ben Ward, CEO of Maricann. “Now, as a public company, we continue to build on that foundation in capitalizing on growth opportunities across the expanding cannabis industry.”



Maricann Group

Maricann’s public listing follows a series of recent transactions and approvals. On April 18, 2017, the shareholders of Maricann Inc. (“Old Maricann”), a private company, approved its previously announced reverse takeover transaction of Danbel Ventures Inc. (“Danbel”), a public company. On April 20, 2017 the reverse takeover of Danbel by the shareholders of Old Maricann was completed and Danbel changed its name to “Maricann Group Inc.” Old Maricann became a wholly owned subsidiary of the Company. On April 21, 2107 Maricann received approval to list its shares for trading on the CSE.

“Countless people worked very hard to get Maricann to this point, with our employees, shareholders, board members, senior executives and a range of suppliers putting their faith in our growth strategy,” said Ben. “We are moving forward on the path to becoming one of the world’s leading vertically integrated cannabis companies.”

Maricann Milestones

-April 2013, Maricann Inc. is founded in Langton, Ontario, a well-established agricultural region in southwestern Ontario

-March 2014, Maricann Inc. obtains its Health Canada licence to cultivate plants

-December 2014, Maricann Inc. obtains its Health Canada licence to sell dried cannabis

-January 2015, first dried cannabis sale

-September 2016, Maricann Inc. earns its Health Canada licence to sell cannabis extracts

-October 2016, first sale of extracted cannabis

-December 2016, Maricann Inc. raises $22.5 million in private capital

-January 2017, commences sale of clones

-February 2017, Maricann Inc. raises $10 million in private capital

-April 20, 2017, Maricann Inc. completes a reverse takeover of Danbel Ventures Inc. which becomes Maricann Group Inc.

-April 24, 2017, first day of trading on the CSE

About Maricann

Maricann is a vertically integrated low cost greenhouse producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal licence to cultivate cannabis and one of approximately 30 independent licensed producers with a federal licence to process and distribute cannabis, Maricann services a patient base with more than 8,000 registered patients. Maricann is currently undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.

Like up on FACEBOOK


Ebates Coupons and Cash Back



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Buz Investors EURUSD Marginally Higher A very light economic calendar and some easing political concerns are resulting in a modest gain in EUR/USD in today’s trading. The pair is currently at 1.0619, up 0.10% over Friday’s close.

EURUSD Euro was trading above 1.08 to USD

EURUSD Euro was trading above 1.08 to USD

Buz Investors Euro was trading above 1.08 This morning at 09:40 GMT, the EUR is trading at 1.0791 against the USD, 0.52% higher from the New York close.

EURUSD

Buz Investors Euro was trading above 1.08 This morning at 09:40 GMT, the EUR is trading at 1.0791 against the USD, 0.52% higher from the New York close. Going ahead, investors’ will look forward to the Eurozone’s current account figures, due to release tomorrow. This morning, the pair traded at a high of 1.0804 and a low of 1.0717. The Euro traded 0.17% lower against the US Dollar in the New York session yesterday, with the pair closing the session at 1.0735. The pair is expected to its find support at 1.0737 and its first resistance at 1.0824.



OTHER STORIES BUZ TRADERS FOLLOW

Euro was trading above 1.08

Eurozone’s current account figures, due to release tomorrow. This morning,

The Euro was trading above 1.08 to USD on Thursday morning, the highest in nearly two months. The strength comes after centrist Emmanuel Macron took a slim lead in the French first round voting intentions, taking over rivals Marine Le Pen and Francois Fillon following a televised debate on Monday night. Historically, the Euro Dollar Exchange Rate – EUR/USD reached an all time high of 1.87 in July of 1973 and a record low of 0.70 in February of 1985. The euro was only introduced as a currency on the first of January of 1999. However, synthetic historical prices going back much further can be modeled if we consider a weighted average of the previous currencies.

The EURUSD spot exchange rate specifies how much one currency, the EUR, is currently worth in terms of the other, the USD. While the EURUSD spot exchange rate is quoted and exchanged in the same day, the EURUSD forward rate is quoted today but for delivery and payment on a specific future date. This page provides the latest reported value for – Euro Dollar Exchange Rate – EUR/USD – plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news. Euro Dollar Exchange Rate – EUR/USD – actual data, historical chart and calendar of releases – was last updated on March of 2017.


Ebates Coupons and Cash Back



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD)